BioNxt Solutions Inc. (CSE:BNXT)
0.5700
-0.0300 (-5.00%)
At close: Feb 9, 2026
BioNxt Solutions Market Cap
BioNxt Solutions has a market cap or net worth of CAD 70.07 million as of February 9, 2026. Its market cap has increased by 45.25% in one year.
Market Cap
70.07M
Enterprise Value
77.94M
Revenue
15.82K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.57
Market Cap Chart
Since August 6, 2019, BioNxt Solutions's market cap has increased from 47.11M to 70.07M, an increase of 48.75%. That is a compound annual growth rate of 6.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 73.76M | -5.91% |
| Dec 31, 2025 | 78.39M | 81.91% |
| Dec 31, 2024 | 43.09M | -17.23% |
| Dec 29, 2023 | 52.06M | -3.25% |
| Dec 30, 2022 | 53.81M | -35.83% |
| Dec 31, 2021 | 83.87M | -27.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLS Therapeutics | 140.73M |
| Grown Rogue International | 139.97M |
| Charlotte's Web Holdings | 113.38M |
| Medexus Pharmaceuticals | 91.73M |
| Planet 13 Holdings | 77.12M |
| Vext Science | 70.29M |
| LSL Pharma Group | 63.03M |
| ZYUS Life Sciences | 52.05M |